Clinical trial
Adjunctive Isradipine for the Treatment of Bipolar Depression
NCT01784666 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive Isradipine for the Treatment of Bipolar Depression
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 28, 2013
- Completion date
- April 30, 2014
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.